Premium
Linear Immunoglobulin A Bullous Disease of Childhood Responsive to Intravenous Immunoglobulin Monotherapy
Author(s) -
Nanda Arti,
Khawaja Fatima,
Nanda Mousmee,
AlSabah Humoud,
Selim Mohamed K.,
Dvorak Richard,
Alsaleh Qasem A.
Publication year - 2011
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/j.1525-1470.2011.01475.x
Subject(s) - dapsone , medicine , antibody , immunoglobulin g , intravenous immunoglobulin therapy , immunoglobulin a , disease , immunology , gastroenterology
We report a case of linear immunoglobulin A bullous disease in a 9‐year‐old boy who presented with rapidly progressive severe disease and could not tolerate dapsone because of high liver enzymes within a week after a low dose of dapsone in association with an underlying fatty liver. He showed remarkable improvement with intravenous immunoglobulins used as monotherapy, with a rapid clearance and a sustained remission after stopping the treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom